drugset / Trial / NCT04472299
Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose if this pilot study is to determine if a perioperative infusion of 0.2% ropivacaine via bilateral T3 paravertebral catheters can decrease the incidence of new onset atrial fibrillation following primary CABG and/or valve surgery and compare a number of secondary outcomes.
Timeline
- Start
- 2021-04-09
- Primary completion
- 2025-07-08
- Completion
- 2025-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 0.2 % | Other |
| Subject | Ropivacaine | Other / unclassified | 7 ml | Other |